Product Images Ioflupane I 123

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Ioflupane I 123 NDC 69945-166 by Curium Us Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Table 1 - ioflupane i 123 1

Table 1 - ioflupane i 123 1

This is a table showing the absorbed dose per unit administered activity (uGy/MBaq) of various organs and tissues in the body such as adrenal, breast, stomach wall, heart wall, kidney, liver, muscle, pancreas, red marrow, spleen, and testes. The effective dose per unit administered activity (uSvIMBa) is also given as 213.*

Figure 1,2,3,4 - ioflupane i 123 2

Figure 1,2,3,4 - ioflupane i 123 2

The following structural formula for Ioflupane I 123 Injection is a sterile, pyrogen-free radiopharmaceutical for intravenous injection. The clear and colorless solution is supplied in single-use vials in which each milliliter contains 0.07 to 0.13 mcg ioflupane, 74 MBq (2 mCi) of iodine 123 (as ioflupane I 123) at calibration time, 5.7 mg acetic acid, 7.8 mg sodium acetate and 0.05 mL (5%) ethanol. - ioflupane i 123 3

The following structural formula for Ioflupane I 123 Injection is a sterile, pyrogen-free radiopharmaceutical for intravenous injection. The clear and colorless solution is supplied in single-use vials in which each milliliter contains 0.07 to 0.13 mcg ioflupane, 74 MBq (2 mCi) of iodine 123 (as ioflupane I 123) at calibration time, 5.7 mg acetic acid, 7.8 mg sodium acetate and 0.05 mL (5%) ethanol. - ioflupane i 123 3

R102021 Can label - ioflupane i 123 4

R102021 Can label - ioflupane i 123 4

This is a description of a radiopharmaceutical called loflupane 1123, available in the form of single-dose vials for intravenous administration. Loflupane 1123 is a radioactive injection with a concentration of 74 MBq/mL (2 mCi/mL). The recommended dosage of this drug is specified in the Prescribing Information. The total activity of each injection at calibration is 185 MBq (5 mCi) in a volume of 2.5 mL. The drug must be stored upright at controlled room temperature in a shielded container, and the unused portion of a single-dose vial must be discarded. The calibration date is mentioned, and it is specified that the drug expires 7 hours after calibration time. The description also includes a lot number and a manufacturer's name.*

R122021 Vial label - ioflupane i 123 5

R122021 Vial label - ioflupane i 123 5

This is a description of a radiopharmaceutical product labeled with a National Drug Code (NDC) 69945-166-05, provided in a single-dose vial. It contains 185 MBq (5 mCi) of loflupane | 123 at calibration, with a radioactive concentration of 74 MBq (2 mCi) per 1 mL. The product is recommended for intravenous use only and should be discarded if the unused portion is left. In addition, the product must be stored at controlled room temperature ranging from 20°C to 25°C (68°F to 77°F) upright in a shielded container to prevent radiological hazards. The volume of the product is 2.5 mL for calibration, and its shelf life expires after 7 hours of calibration time. However, the dosage of the product is not available, and the prescribing information must be consulted. The radiopharmaceutical is manufactured by Curium US LLC, and the lot number is 1234567890, with a calibration date of R12/2021.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.